FIELD: molecular biology.
SUBSTANCE: described is a method for quantitative assessment of human T and B lymphocytes by digital polymerase chain reaction, characterized by the fact that an accurate assessment of the number of human T and B-lymphocytes in a biological sample is achieved by counting copies of signal fragments of excision rings TREC and KREC of genes, as well as a gene.
EFFECT: high accuracy of quantitative assessment of T and B-lymphocytes in human biological samples of interest.
1 cl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| pGEM-TCRAC-sjTREC-sjKREC RECOMBINANT PLASMID DNA CONTAINING NUCLEOTIDE SEQUENCES OF THE T-LYMPHOCYTE Α-RECEPTOR GENE LOCUS AND SIGNAL FRAGMENTS OF THE T- AND B-CELL RECEPTOR EXCISION RINGS | 2022 |
|
RU2807806C1 |
| METHOD FOR DETERMINING THE SUBLINES OF THE TUBERCULOSIS CAUSATIVE AGENT OF THE L2 beijing LINE ON BIOLOGICAL MICROCHIPS | 2022 |
|
RU2790296C1 |
| METHOD FOR MULTIPLEX IDENTIFICATION OF 32 FLAX GENETIC MARKERS | 2022 |
|
RU2804939C1 |
| METHOD FOR GENOTYPING NEISSERIA GONORRHOEAE ISOLATES ON BIOLOGICAL MICROCHIP | 2023 |
|
RU2816767C1 |
| SET OF PRIMERS FOR THE DETECTION OF STREPTOCOCCUS MUTANS BY ISOTHERMAL LOOP AMPLIFICATION | 2022 |
|
RU2799414C1 |
| METHOD OF DETECTING STREPTOCOCCUS MUTANS BY ISOTHERMAL LOOP AMPLIFICATION | 2022 |
|
RU2799413C1 |
| NUCLEIC ACID FOR ALLOTOPIC EXPRESSION OF MT-ND4 GENE | 2023 |
|
RU2809065C1 |
| MONOCLONAL ANTIBODY IC2 AND ITS ANTIGEN-BINDING FRAGMENT, SELECTIVELY BINDING RECEPTOR-BINDING DOMAIN OF SPIKE PROTEIN OF SARS-CoV-2 VIRUS, HAVING VIRUS-NEUTRALIZING ACTIVITY | 2023 |
|
RU2817697C1 |
| METHOD FOR GENOTYPING POLYMORPHIC LOCUS rs7155973 (A>G) OF HSP90AA1 GENE IN HUMAN BY REAL-TIME PCR USING ALLELE-SPECIFIC FLUORESCENT PROBES | 2024 |
|
RU2821923C1 |
| GENETIC VECTOR Ad6/3-hTERT-GMCSF CONTAINING GENOMIC SEQUENCES OF RECOMBINANT ADENOVIRUS SEROTYPE 6, HUMAN TELOMERASE PROMOTER, HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE, AS WELL AS FIBER PROTEIN GENE WITH INSERTION OF FIBER KNOB DOMAIN OF ADENOVIRUS SEROTYPE 3 WITH INCREASED TRANSDUCTION INTO TUMOR CELLS | 2023 |
|
RU2814581C1 |
